Bayesian network modeling of risk and prodromal markers of Parkinson's disease

PLoS One. 2023 Feb 24;18(2):e0280609. doi: 10.1371/journal.pone.0280609. eCollection 2023.

Abstract

Parkinson's disease (PD) is characterized by a long prodromal phase with a multitude of markers indicating an increased PD risk prior to clinical diagnosis based on motor symptoms. Current PD prediction models do not consider interdependencies of single predictors, lack differentiation by subtypes of prodromal PD, and may be limited and potentially biased by confounding factors, unspecific assessment methods and restricted access to comprehensive marker data of prospective cohorts. We used prospective data of 18 established risk and prodromal markers of PD in 1178 healthy, PD-free individuals and 24 incident PD cases collected longitudinally in the Tübingen evaluation of Risk factors for Early detection of NeuroDegeneration (TREND) study at 4 visits over up to 10 years. We employed artificial intelligence (AI) to learn and quantify PD marker interdependencies via a Bayesian network (BN) with probabilistic confidence estimation using bootstrapping. The BN was employed to generate a synthetic cohort and individual marker profiles. Robust interdependencies were observed for BN edges from age to subthreshold parkinsonism and urinary dysfunction, sex to substantia nigra hyperechogenicity, depression, non-smoking and to constipation; depression to symptomatic hypotension and excessive daytime somnolence; solvent exposure to cognitive deficits and to physical inactivity; and non-smoking to physical inactivity. Conversion to PD was interdependent with prior subthreshold parkinsonism, sex and substantia nigra hyperechogenicity. Several additional interdependencies with lower probabilistic confidence were identified. Synthetic subjects generated via the BN based representation of the TREND study were realistic as assessed through multiple comparison approaches of real and synthetic data. Altogether our work demonstrates the potential of modern AI approaches (specifically BNs) both for modelling and understanding interdependencies between PD risk and prodromal markers, which are so far not accounted for in PD prediction models, as well as for generating realistic synthetic data.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artificial Intelligence
  • Bayes Theorem
  • Humans
  • Parkinson Disease*
  • Parkinsonian Disorders*
  • Prodromal Symptoms
  • Prospective Studies

Grants and funding

The TREND study is being conducted at the University Hospital Tübingen and has been supported by the Hertie Institute for Clinical Brain Research, the DZNE, the Geriatric Center of Tübingen, the Center for Integrative Neuroscience, Teva Pharmaceutical Industries, Union Chimique Belge, Janssen Pharmaceuticals, the International Parkinson Foundation and the German Research Society (DFG). This work was (partially) funded by DIGIPD (01KU2110), a project supported by the Federal Ministry of Science and Education (BMBF), under the frame of ERA PerMed. HUZ is supported by the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung; BMBF) within the framework of the e:Med research and funding concept (grant 01ZX1912A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. There was no additional external funding received for this study.